United Laboratories International Holdings Ltd

Company Profile

• Business description

  United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. The majority of the company's sales are generated in China, followed by Europe, India and other countries.

• Contact

  No. 6 Fuk Wang Street
  Yuen Long Industrial Estate
  New Territories
  Hong Kong
  HKG

  T: +852 26871033

  http://www.tul.com.cn

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Drug Manufacturers - Specialty & Generic

  Fiscal Year End

  31 December 2025

  Employees

  17,000